HCA Healthcare's Q2 earnings beat expectations with $20.23B in revenue and adjusted earnings of $7.59 per share. Analysts lower price targets.
HCA Healthcare Inc.
(NYSE:HCA) on Friday posted upbeat second-quarter earnings.
The company posted second-quarter 2026 revenues of $20.23 billion, representing an 8.7% year-over-year increase, beating the consensus estimate of $19.40 billion.
The company reported adjusted earnings of $7.59, up from $6.84 a year ago, surpassing the Wall Street estimates of $7.02.
HCA Healthcare reaffirmed fiscal 2026 earnings guidance of $28.70-$30.50 per share compared to the consensus of $29.70.
HCA Healthcare beat Q2 revenue and earnings estimates as admissions rose, while a payer mix shift and lower surgical volumes…
HCA Healthcare's preliminary Q2 results showed higher revenue and EPS despite a $400 million hit from a shift toward uninsured…
HCA Healthcare sent out a pre-earnings shockwave Tuesday morning with preliminary second-quarter results suggesting that coverage…
Universal Health Services (NYSE: UHS) reported strong Q2 results and lowered FY26 EPS guidance. Share price up 0.6%. Analysts…
In a report released on July 9, Ben Hendrix from RBC Capital maintained a Buy rating on HCA Healthcare, with a price target of…
In a report released on June 8, Andrew Mok CFA from Barclays maintained a Buy rating on HCA Healthcare, with a price target of…
GE HealthCare sees Q2 earnings growth above prior expectation
HCA Healthcare's H1 ACA volume dropoffs 'almost one for one' shifted to uninsurance
Humana tops quarterly estimates, maintains profit outlook as medical costs stay in line
Universal Health Services tops Q2 expectations, but dials back full-year earnings
Community Health Systems misses on Q2 earnings, revenue
HSBC Sticks to Its Hold Rating for Hygeia Healthcare Holdings Co., Ltd. (6078)
GE HealthCare affirms fiscal 2026 outlook provided on April 29
